HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Microplastic In EU: Cosmetics Europe Chief On Best And Worst-Case Restriction Scenarios

Executive Summary

Leave-on cosmetics and their manufacturers are virtually certain to take significant hits under the European Chemicals Agency’s developing microplastic restriction. As ECHA committees prepare to publish opinions on the matter, the big question for cosmetic stakeholders is just how costly and disruptive the measure will be.

You may also be interested in...



US States Take Aim At Microplastics Among ‘Overwhelming’ Number Of Bills With Cosmetics Relevance

Plastic concerns loom large in a growing patchwork of legislative proposals at the US state level with implications for cosmetics businesses.

ECHA Defends Proposal For ‘World’s Broadest’ Microplastic Restriction Amid NGO Criticism

NGOs claim the European Chemicals Agency’s proposal for restricting microplastics in cosmetics and other products could “make a growing problem worse” by excluding particles smaller than 100 nanometers. The agency clapped back on 1 September, maintaining its proposal was developed in a scientific manner based on input from all stakeholders, including NGOs.

ECHA Committee Stops Short Of Advising Derogation Or Deadline Extension For Cosmetic Microplastic Ban

Uncertainties related to leave-on cosmetics’ microplastic releases to the environment, and the costs industry would face in removing microplastic from such products, “do not allow for SEAC to conclude whether other options would be more appropriate than a ban,” the European Chemicals Agency’s Socio-Economic Analysis Committee says in a 1 July draft opinion.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel